In this manuscript, we investigate the role of IL13RA2 in growth of DIPG and validate the potential of an anti-IL13Rα2 antibody–drug conjugate as a potential novel treatment for DIPG. This evidence concerns the gene IL13RA2 and diffuse intrinsic pontine glioma.